Gene Therapy for SCID Market

Gene Therapy for SCID Market Analysis, By Type of SCID (X-Linked SCID, ADA-SCID, and Other SCID Types), By Therapy Type (Gene Replacement Therapy, Gene Editing Therapy, and Stem Cell Gene Therapy), By Vector Type (Viral Vectors and Non-Viral Vectors), By Patient Age Group (Pediatric Patients and Adult Patients), By Pricing Model (Single-dose treatments and Multi-dose treatments, and Region - Market Insights 2024 to 2034

Analysis of Gene Therapy for SCID Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

1. Executive Summary

2. Industry Introduction, including Taxonomy and Market Definition

3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments

4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    5.1. Type of SCID

    5.2. Therapy Type

    5.3. Vector Type

    5.4. Patient Age Group

    5.5. Pricing Model

    5.6. Phase of Development

    5.7. End-User

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type of SCID

    6.1. X-Linked SCID

    6.2. ADA-SCID

    6.3. Other SCID Types

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy Type

    7.1. Gene Replacement Therapy

    7.2. Gene Editing Therapy

    7.3. Stem Cell Gene Therapy

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Vector Type

    8.1. Viral Vectors

    8.2. Non-Viral Vectors

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Patient Age Group

    9.1. Pediatric Patients

    9.2. Adult Patients

10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Pricing Model

    10.1. Single-dose treatments

    10.2. Multi-dose treatments

11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phase of Development

    11.1. Preclinical

    11.2. Clinical Trials

    11.3. Commercialized

12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User

    12.1. Hospitals

    12.2. Specialty Clinics

    12.3. Research Institutions

13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    13.1. North America

    13.2. Latin America

    13.3. Western Europe

    13.4. Eastern Europe

    13.5. East Asia

    13.6. South Asia & Pacific

    13.7. MEA

14. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

15. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

16. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

17. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

18. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

19. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

20. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

21. Sales Forecast 2024 to 2034 by Type of SCID, Therapy Type, Vector Type, Patient Age Group, Pricing Model, Phase of Development, and End-User for 30 Countries

22. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard

23. Company Profile

    23.1. Orchard Therapeutics plc.

    23.2. OSR and Telethon

    23.3. Jasper Therapeutics, Inc.

    23.4. Graphite Bio, Inc.

    23.5. Mustang Bio Inc

    23.6. University of California San Francisco

    23.7. Genethon SA

    23.8. Boston Children's Hospital

    23.9. Shenzhen Geno-Immune Medical Institute

    23.10. University College London

    23.11. University of California Los Angeles

    23.12. The National Institute of Allergy and Infectious Diseases

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 1: Global Market US$ Mn Forecast by Region, 2019-2034

Table 2: Global Market US$ Mn Forecast by Type of SCID, 2019-2034

Table 3: Global Market US$ Mn Forecast by Therapy Type, 2019-2034

Table 4: Global Market US$ Mn Forecast by Vector Type, 2019-2034

Table 5: Global Market US$ Mn Forecast by Patient Age Group, 2019-2034

Table 6: Global Market US$ Mn Forecast by Pricing Model, 2019-2034

Table 7: Global Market US$ Mn Forecast by Phase of Development, 2019-2034

Table 8: Global Market US$ Mn Forecast by End-User, 2019-2034

Table 9: North America Market US$ Mn Forecast by Country, 2019-2034

Table 10: North America Market US$ Mn Forecast by Type of SCID, 2019-2034

Table 11: North America Market US$ Mn Forecast by Therapy Type, 2019-2034

Table 12: North America Market US$ Mn Forecast by Vector Type, 2019-2034

Table 13: North America Market US$ Mn Forecast by Patient Age Group, 2019-2034

Table 14: North America Market US$ Mn Forecast by Pricing Model, 2019-2034

Table 15: North America Market US$ Mn Forecast by Phase of Development, 2019-2034

Table 16: North America Market US$ Mn Forecast by End-User, 2019-2034

Table 17: Latin America Market US$ Mn Forecast by Country, 2019-2034

Table 18: Latin America Market US$ Mn Forecast by Type of SCID, 2019-2034

Table 19: Latin America Market US$ Mn Forecast by Therapy Type, 2019-2034

Table 20: Latin America Market US$ Mn Forecast by Vector Type, 2019-2034

Table 21: Latin America Market US$ Mn Forecast by Patient Age Group, 2019-2034

Table 22: Latin America Market US$ Mn Forecast by Pricing Model, 2019-2034

Table 23: Latin America Market US$ Mn Forecast by Phase of Development, 2019-2034

Table 24: Latin America Market US$ Mn Forecast by End-User, 2019-2034

Table 25: Western Europe Market US$ Mn Forecast by Country, 2019-2034

Table 26: Western Europe Market US$ Mn Forecast by Type of SCID, 2019-2034

Table 27: Western Europe Market US$ Mn Forecast by Therapy Type, 2019-2034

Table 28: Western Europe Market US$ Mn Forecast by Vector Type, 2019-2034

Table 29: Western Europe Market US$ Mn Forecast by Patient Age Group, 2019-2034

Table 30: Western Europe Market US$ Mn Forecast by Pricing Model, 2019-2034

Table 31: Western Europe Market US$ Mn Forecast by Phase of Development, 2019-2034

Table 32: Western Europe Market US$ Mn Forecast by End-User, 2019-2034

Table 33: Eastern Europe Market US$ Mn Forecast by Country, 2019-2034

Table 34: Eastern Europe Market US$ Mn Forecast by Type of SCID, 2019-2034

Table 35: Eastern Europe Market US$ Mn Forecast by Therapy Type, 2019-2034

Table 36: Eastern Europe Market US$ Mn Forecast by Vector Type, 2019-2034

Table 37: Eastern Europe Market US$ Mn Forecast by Patient Age Group, 2019-2034

Table 38: Eastern Europe Market US$ Mn Forecast by Pricing Model, 2019-2034

Table 39: Eastern Europe Market US$ Mn Forecast by Phase of Development, 2019-2034

Table 40: Eastern Europe Market US$ Mn Forecast by End-User, 2019-2034

Table 41: East Asia Market US$ Mn Forecast by Country, 2019-2034

Table 42: East Asia Market US$ Mn Forecast by Type of SCID, 2019-2034

Table 43: East Asia Market US$ Mn Forecast by Therapy Type, 2019-2034

Table 44: East Asia Market US$ Mn Forecast by Vector Type, 2019-2034

Table 45: East Asia Market US$ Mn Forecast by Patient Age Group, 2019-2034

Table 46: East Asia Market US$ Mn Forecast by Pricing Model, 2019-2034

Table 47: East Asia Market US$ Mn Forecast by Phase of Development, 2019-2034

Table 48: East Asia Market US$ Mn Forecast by End-User, 2019-2034

Table 49: South Asia & Pacific Market US$ Mn Forecast by Country, 2019-2034

Table 50: South Asia & Pacific Market US$ Mn Forecast by Type of SCID, 2019-2034

Table 51: South Asia & Pacific Market US$ Mn Forecast by Therapy Type, 2019-2034

Table 52: South Asia & Pacific Market US$ Mn Forecast by Vector Type, 2019-2034

Table 53: South Asia & Pacific Market US$ Mn Forecast by Patient Age Group, 2019-2034

Table 54: South Asia & Pacific Market US$ Mn Forecast by Pricing Model, 2019-2034

Table 55: South Asia & Pacific Market US$ Mn Forecast by Phase of Development, 2019-2034

Table 56: South Asia & Pacific Market US$ Mn Forecast by End-User, 2019-2034

Table 57: MEA Market US$ Mn Forecast by Country, 2019-2034

Table 58: MEA Market US$ Mn Forecast by Type of SCID, 2019-2034

Table 59: MEA Market US$ Mn Forecast by Therapy Type, 2019-2034

Table 60: MEA Market US$ Mn Forecast by Vector Type, 2019-2034

Table 61: MEA Market US$ Mn Forecast by Patient Age Group, 2019-2034

Table 62: MEA Market US$ Mn Forecast by Pricing Model, 2019-2034

Table 63: MEA Market US$ Mn Forecast by Phase of Development, 2019-2034

Table 64: MEA Market US$ Mn Forecast by End-User, 2019-2034

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019-2034

Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019-2034

Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019-2034

Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019-2034

Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019-2034

Figure 6: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019-2034

Figure 7: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019-2034

Figure 8: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region, 2019-2034

Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019-2034

Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019-2034

Figure 11: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019-2034

Figure 12: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019-2034

Figure 13: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019-2034

Figure 14: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019-2034

Figure 15: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019-2034

Figure 16: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019-2034

Figure 17: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019-2034

Figure 18: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019-2034

Figure 19: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019-2034

Figure 20: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019-2034

Figure 21: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019-2034

Figure 22: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019-2034

Figure 23: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019-2034

Figure 24: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019-2034

Figure 25: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019-2034

Figure 26: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019-2034

Figure 27: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019-2034

Figure 28: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019-2034

Figure 29: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019-2034

Figure 30: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019-2034

Figure 31: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019-2034

Figure 32: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019-2034

Figure 33: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019-2034

Figure 34: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019-2034

Figure 35: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019-2034

Figure 36: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019-2034

Figure 37: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019-2034

Figure 38: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019-2034

Figure 39: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019-2034

Figure 40: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019-2034

Figure 41: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019-2034

Figure 42: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019-2034

Figure 43: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019-2034

Figure 44: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019-2034

Figure 45: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019-2034

Figure 46: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019-2034

Figure 47: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019-2034

Figure 48: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019-2034

Figure 49: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019-2034

Figure 50: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019-2034

Figure 51: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019-2034

Figure 52: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019-2034

Figure 53: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019-2034

Figure 54: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019-2034

Figure 55: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019-2034

Figure 56: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019-2034

Figure 57: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019-2034

Figure 58: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019-2034

Figure 59: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019-2034

Figure 60: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019-2034

Figure 61: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019-2034

Figure 62: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019-2034

Figure 63: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019-2034

Figure 64: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019-2034

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Gene Therapy for SCID Market

Schedule a Call